Biomedical Engineering Reference
In-Depth Information
N., Takahashi, N., and Suda, T.
(1998)
Proc. Natl. Acad. Sci. U.S.A.
,
95
, 3597- 3602.
M.,Davis,R.,Fitzner,J.N.,Johnson,
R.S., Paxton, R.J., March, C.J., and
Cerretti, D.P. (1997) A metallopro-
teinase disintegrin that releases
tumour-necrosis factor-alpha from
cells.
Nature
,
385
(6618), 729- 733.
Yasuda, H., Shima, N., Nakagawa, N.,
Mochizuki, S.I., Yano, K., Fujise, N.,
Sato, Y., Goto, M., Yamaguchi, K.,
Kuriyama,M.,Kanno,T.,Murakami,
A.,Tsuda,E.,Morinaga,T.,and
Higashio, K. (1998)
Endocrinology
,
139
(3), 1329- 1337.
173.
Dziedzic-Goc3awska, A., Tyszkiewicz,
J., and Uhrynowska-Tyszkiewicz, I.
(2000)
Nowa Klin.
,
7
(7), 704- 712.
186.
187.
Pan, B., Farrugia, A.N., To, L.B.,
Findlay,D.M.,Green,J.,Lynch,K.,
and Zannettino, A.C. (2004)
J. Bone
Miner. Res.
,
19
(1), 147- 154.
174.
Kryokiewicz, E. and Lorenc, I.R.S.
(2006)
TERAPIA
,
3
(177), 58- 63.
175.
Malyankar, U.M., Scatena, M.,
Suchland, K.L., Yun, Th.J., Clark,
E.A., and Giachelli, C.M. (2000)
J. Biol.
Chem.
,
275
(28), 20959- 20962.
Wedemeyer, Ch., Knoch, Fv.,
Pingsmann, A., Hilken, G., Sprecher,
Ch., Saxler, G., Henschke, F., Loer, F.,
and Knoch, Mv. (2005)
Biomaterials
,
26
(17), 3719- 3725.
188.
176.
Rogers, A. and Eastell, R. (2005)
J. Clin. Endocrinol. Metab.
,
90
(11),
6323- 6331.
189.
Stawi nska, N., Zi¸tek, M., and
Kochanowska, I. (2005)
Dent. Med.
Prob.
,
42
(4), 627- 635.
177.
Boyce, B.F. and Xing, L. (2007)
Arthritis
Res. Ther.
,
9
(Suppl 1), 1-7.
Bucay,N.,Sarosi,I.,Dunstan,C.R.,
Morony, S., Tarpley, J., Capparelli, C.,
Scully,Sh.,Tan,H.L.,Xu,W.,Lacey,
D.L.,Boyle,W.J.,andScottSimonet,
W. (1998)
Genes Dev.
,
12
, 1260- 1268.
178.
Khosla, S. (2001) Minireview: the
OPG/RANKL/RANK system.
En-
docrinology
,
142
(12), 5050- 5055.
190.
191.
Kearns, A.E., Khosla, S., and
Kostenuik, P.J. (2008)
Endocrinol.
Rev.
,
29
(2), 155- 192.
179.
Ducy, P., Schinke, Th., and Karsenty,
G. (2000)
Science
,
289
(5484),
1501- 1504.
McClung, M. (2007)
Arthritis Res. Ther.
,
9
(Suppl 1), 1-3.
192.
180.
Boyle, W.J., Simonet, W.S., and
Lacey, D.L. (2003)
Nature
,
423
(6937),
337- 342.
193.
Yeung, Rae S.M. (2004) The Osteopro-
tegerin/Osteoprotegerin ligand family:
role in inflammation and bone loss.
J.
Rheumatol.
,
31
(5), 844- 846.
181.
Schoppet, M., Preissner, K.T., and
HofbauerI, L.C. (2002)
Arterioscler.
Thromb. Vasc. Biol.
,
22
(4), 549- 553.
194.
Kong, Y.Y., Yoshida, H., Sarosi, I.,
Tan, H.L., Timms, E., Capparelli, C.,
Morony, S., Oliveira-dos-Santos, A.J.,
Van,G.,Itie,A.,Khoo,W.,Wakeham,
A.,Dunstan,C.R.,Lacey,D.L.,Mak,
T.W., Boyle, W.J., and Penninger, J.M.
(1999)
Nature
,
397
(6717), 315- 323.
182.
Hofbauer, L.C. and Schoppet, M.
(2004)
J. Am. Med. Assoc.
,
292
,
490- 495.
183.
Bekker, P.J., Holloway, D.L.,
Rasmussen, A.S., Murphy, R., Martin,
S.W., Leese, Ph.T., Holmes, G.B.,
Dunstan, C.R., and DePaoli, A.M.
(2004) A single-dose placebo-controlled
study of AMG 162, a fully human
monoclonal antibody to RANKL.
J.
Bone Miner. Res.
,
19
(7), 1059- 1066.
195.
Silvestrini, G., Ballanti, P., Patacchioli,
F., Leopizzi, M., Gualtieri, N.,
Monnazzi,P.,Tremante,E.,Sardella,
D., and Bonucci, E. (2005) Detection of
osteoprote gerin (OPG) and its ligand
(RANKL) mRNA and protein infe-
mur and tibia of the rat.
J. Mol. Hist.
,
36
(1-2), 59-67.
184.
Black, R.A. (2002) Tumor necrosis
factor-alpha converting enzyme.
Int. J.
Biochem. Cell Biol.
,
34
(1), 1-5.
196.
Kim, D.W., Lee, H.J., Karmin, J.A.,
Lee,S.E.,Chang,S.S.,Tolchin,B.,Lin,
S., Cho, S.K., Kwon, A., Ahn, J.M., and
Lee, F.Y.-I. (2006)
Ann. N.Y. Acad. Sci.
,
1068
(1), 568- 572.
185.
Black, R.A., Rauch, C.T., Kozlosky,
C.J., Peschon, J.J., Slack, J.L., Wolfson,
M.F.,Castner,B.J.,Stocking,K.L.,
Reddy, P., Srinivasan, S., Nelson, N.,
Boiani, N., Schooley, K.A., Gerhart,
